AAAAAA
Results:
1-23
|
Results: 23
Authors:
Trope, C
Kristensen, GB
Abeler, VM
Citation: C. Trope et al., Clear-cell and papillary serous cancer: treatment options, BEST P R CL, 15(3), 2001, pp. 433-446
Authors:
Trope, C
Kaern, J
Hogberg, T
Abeler, V
Hagen, B
Kristensen, G
Onsrud, M
Pettersen, E
Rosenberg, P
Sandvei, R
Sundfor, K
Vegote, I
Citation: C. Trope et al., Randomized study on adjuvant chemotherapy in stage I high-risk ovarian cancer with evaluation of DNA-ploidy as prognostic instrument, INT J GYN C, 11, 2001, pp. 20-20
Authors:
Trope, C
Kristensen, G
Kisic, J
Kaern, J
Citation: C. Trope et al., Long-term results from a phase II study of paclitaxel combined with doxorubicin in recurrent platinum refractory ovarian cancer, EUR J GYN O, 22(3), 2001, pp. 223-227
Authors:
Makar, AP
Trope, C
Citation: Ap. Makar et C. Trope, Fertility preservation in gynecologic cancer, ACT OBST SC, 80(9), 2001, pp. 794-802
Authors:
Piccart, MJ
Bertelsen, K
James, K
Cassidy, J
Mangioni, C
Simonsen, E
Stuart, G
Kaye, S
Vergote, I
Blom, R
Grimshaw, R
Atkinson, RJ
Swenerton, KD
Trope, C
Nardi, M
Kaern, J
Tumolo, S
Timmers, P
Roy, JA
Lhoas, F
Lindvall, B
Bacon, M
Birt, A
Andersen, JE
Zee, B
Paul, J
Baron, B
Pecorelli, S
Citation: Mj. Piccart et al., Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: Three-year results, J NAT CANC, 92(9), 2000, pp. 699-708
Authors:
Lyng, H
Sundfor, K
Trope, C
Rofstad, EK
Citation: H. Lyng et al., Disease control of uterine cervical cancer: Relationships to tumor oxygen tension, vascular density, cell density, and frequency of mitosis and apoptosis measured before treatment and during radiotherapy, CLIN CANC R, 6(3), 2000, pp. 1104-1112
Authors:
Trope, C
Marth, C
Kaern, J
Citation: C. Trope et al., Tamoxifen in the treatment of recurrent ovarian carcinoma, EUR J CANC, 36, 2000, pp. S59-S61
Authors:
Trope, C
Kaern, J
Hogberg, T
Abeler, V
Hagen, B
Kristensen, G
Onsrud, M
Pettersen, E
Rosenberg, P
Sandvei, R
Sundfor, K
Vergote, I
Citation: C. Trope et al., Randomized study on adjuvant chemotherapy in stage I high-risk ovarian cancer with evaluation of DNA-ploidy as prognostic instrument, ANN ONCOL, 11(3), 2000, pp. 281-288
Authors:
Bye, A
Trope, C
Loge, JH
Hjermstad, M
Kaasa, S
Citation: A. Bye et al., Health-related quality of life and occurrence of intestinal side effects after pelvic radiotherapy - Evaluation of long-term effects of diagnosis andtreatment, ACTA ONCOL, 39(2), 2000, pp. 173-180
Authors:
Paulsen, T
Marth, C
Kaern, J
Nustad, K
Kristensen, GB
Trope, C
Citation: T. Paulsen et al., Effects of paclitaxel on CA-125 serum levels in ovarian cancer patients, GYNECOL ONC, 76(3), 2000, pp. 326-330
Authors:
Dorum, A
Hovig, E
Trope, C
Inganas, M
Moller, P
Citation: A. Dorum et al., Three per cent of Norwegian ovarian cancers are caused by BRCA1 1675delA or 1135insA, EUR J CANC, 35(5), 1999, pp. 779-781
Authors:
Berek, JS
Trope, C
Vergote, I
Citation: Js. Berek et al., Surgery during chemotherapy and at relapse of ovarian cancer, ANN ONCOL, 10, 1999, pp. 3-7
Authors:
Ozols, RF
Gore, M
Trope, C
Grenman, S
Citation: Rf. Ozols et al., Intraperitoneal treatment and dose-intense therapy in ovarian cancer, ANN ONCOL, 10, 1999, pp. 59-64
Authors:
Piccart, MJ
Stuart, GCE
Cassidy, J
Bertelsen, K
Parmar, MKB
Eisenhauer, EA
Kaye, SB
Trope, C
Swenerton, K
Harper, P
Vermorken, JB
Citation: Mj. Piccart et al., Intergroup collaboration in ovarian cancer: a giant step forward, ANN ONCOL, 10, 1999, pp. 83-86
Authors:
Berek, JS
Bertelsen, K
du Bois, A
Brady, MF
Carmichael, J
Eisenhauer, EA
Gore, M
Grenman, S
Hamilton, TC
Hansen, SW
Harper, PG
Horvath, G
Kaye, SB
Luck, HJ
Lund, B
McGuire, WP
Neijt, JP
Ozols, RF
Parmar, MKB
Piccart-Gebhart, MJ
van Rijswijk, R
Rosenberg, P
Rustin, GJS
Sessa, C
Thigpen, JT
Trope, C
Tuxen, MK
Vergote, I
Vermorken, JB
Willemse, PHB
Citation: Js. Berek et al., Advanced epithelial ovarian cancer: 1998 consensus statements, ANN ONCOL, 10, 1999, pp. 87-92
Authors:
Marth, C
Sundfor, K
Kaern, J
Trope, C
Citation: C. Marth et al., Long-term follow-up of neoadjuvant cisplatin and 5-fluorouracil chemotherapy in bulky squamous cell carcinoma of the cervix, ACTA ONCOL, 38(4), 1999, pp. 517-520
Authors:
Sundfor, K
Trope, C
Suo, ZH
Bergsjo, P
Citation: K. Sundfor et al., Normobaric oxygen treatment during radiotherapy for carcinoma of the uterine cervix. Results from a prospective controlled randomized trial, RADIOTH ONC, 50(2), 1999, pp. 157-165
Authors:
Kristensen, GB
Abeler, VM
Risberg, B
Trope, C
Bryne, M
Citation: Gb. Kristensen et al., Tumor size, depth of invasion, and grading of the invasive tumor front arethe main prognostic factors in early squamous cell cervical carcinoma, GYNECOL ONC, 74(2), 1999, pp. 245-251
Authors:
Skomedal, H
Kristensen, GB
Nesland, JM
Borresen-Dale, AL
Trope, C
Holm, R
Citation: H. Skomedal et al., TP53 alterations in relation to the cell cycle-associated proteins p21, cyclin D1, cdk4, RB, MDM2, and EGFR in cancers of the uterine corpus, J PATHOLOGY, 187(5), 1999, pp. 556-562
Authors:
Scheistroen, M
Trope, C
Pettersen, EO
Nesland, JM
Citation: M. Scheistroen et al., p53 protein expression in squamous cell carcinoma of the vulva, CANCER, 85(5), 1999, pp. 1133-1138
Authors:
Dorum, A
Heimdal, K
Lovslett, K
Kristensen, G
Hansen, LJ
Sandvei, R
Schiefloe, A
Hagen, B
Himmelmann, A
Jerve, F
Shetelig, K
Fjaerestad, I
Trope, C
Moller, P
Citation: A. Dorum et al., Prospectively detected cancer in familial breast/ovarian cancer screening, ACT OBST SC, 78(10), 1999, pp. 906-911
Authors:
Trope, C
Hogberg, T
Kaern, J
Bertelsen, K
Bjorkholm, E
Boman, K
Himmelmann, A
Horvath, G
Jacobsen, A
Kuoppola, T
Vartianen, J
Lund, B
Onsrud, M
Puistola, U
Salmi, T
Scheistroen, M
Sandvei, R
Simonsen, E
Sorbe, B
Tholander, B
Westberg, R
Citation: C. Trope et al., Long-term results from a phase II study of single agent paclitaxel (Taxol (R)) in previously platinum treated patients with advanced ovarian cancer: The Nordic experience, ANN ONCOL, 9(12), 1998, pp. 1301-1307
Authors:
Paulsen, T
Kaern, J
Trope, C
Citation: T. Paulsen et al., Carboplatin/5-fluorouracil treatment of recurrent cervical carcinoma: a phase II study with long-term follow-up, EUR J GYN O, 19(6), 1998, pp. 524-528
Risultati:
1-23
|